NTN1 and type 2 diabetes mellitus: A down-regulation of netrin-1 has also been observed in inflammatory and autoimmune diseases, such as multiple sclerosis (Mulero et al., 2017), type 2 diabetes mellitus patients (Liu et al., 2016), aneurysmal subarachnoid hemorrhage (Chen J.-L.